melanoma

Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK
Fierce Pharma
Tue, 09/1/15 - 06:35 pm
Novartis
Europe
melanoma
GSK
Mekinist
Tafinlar
Former U.S. President Carter gets powerful immune-system boosting drug
Yahoo/Reuters
Fri, 08/21/15 - 08:47 am
Jimmy Carter
melanoma
Merck
Keytruda
anti-PD-1 immunotherapy
Merck's Keytruda ready for quick FDA action on big melanoma expansion
Fierce Pharma
Tue, 08/18/15 - 01:36 pm
Merck
Keytruda
FDA
melanoma
Why the FDA Extended Review Date on Key Melanoma Drug Opdivo
24/7 Wall St
Thu, 08/13/15 - 08:43 am
melanoma
FDA
Opdivo
Bristol-Myers Squibb
Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma
Yahoo
Mon, 08/10/15 - 08:08 am
Keytruda
Immune Design
Merck
clinical trials
melanoma
non-Hodgkin's lymphoma
LV305
G100
Novartis melanoma drug combination wins EU green light
Yahoo/Reuters
Sat, 07/25/15 - 09:38 am
Novartis
melanoma
Europe
Mekinist
Tafinlar
GSK
Immunocore to Accelerate Cancer Program With $320 Million Raised
Bloomberg
Thu, 07/16/15 - 10:24 pm
Immunocore
IMCgp100
melanoma
FDA taps the brakes on Genentech's cobimetinib review
Fierce Biotech
Wed, 07/1/15 - 04:08 pm
FDA
Genentech
Cobimetinib
melanoma
Exelixis
Should Bristol-Myers cut payer deals to boost melanoma combo over one-drug treatments?
Fierce Pharma Marketing
Mon, 06/29/15 - 11:32 am
melanoma
Bristol-Myers Squibb
payer negotiation
Yervoy
Opdivo
Viagra, Melanoma And The Problem With Big Data
Forbes
Fri, 06/26/15 - 12:45 pm
Viagra
melanoma
Big Data
Pfizer (PFE) Stock Falling on Study Possibly Linking Viagra to Melanoma
TheStreet.com
Wed, 06/24/15 - 06:16 pm
Pfizer
Viagra
erectile dysfunction
melanoma
FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma Drug
Forbes
Wed, 04/29/15 - 06:31 pm
FDA
Amgen
melanoma
Talimogene Laherparepvec
T-Vec
Bristol-Myers: 2 immunotherapy drugs up survival over 1 in melanoma, but worsen side effects
Yahoo/AP
Mon, 04/20/15 - 10:34 am
Bristol-Myers Squibb
Yervoy
Opdivo
melanoma
Merck cancer drug is first approved under UK early access scheme
Yahoo/Reuters
Wed, 03/11/15 - 10:43 am
Merck
Keytruda
UK
melanoma
FDA Accepts Bristol-Myers Squibb Co Supplemental Yervoy BLA For Melanoma
Bidness Etc.
Tue, 03/3/15 - 08:32 am
FDA
Yervoy
Bristol-Myers Squibb
melanoma
Gilead's hep C star Harvoni, BMS' cancer med Opdivo lead ranks of 'exciting' launches
Fierce Pharma Marketing
Thu, 02/26/15 - 10:23 am
Gilead Sciences
Harvoni
hepatitis C
Bristol-Myers Squibb
Opdivo
melanoma
lung cancer
Roche and Exelixis roll toward FDA approval with a melanoma cocktail
Fierce Biotech
Thu, 02/19/15 - 10:41 am
Roche
Exelixis
FDA
melanoma
Cobimetinib
Zelboraf
BRAF inhibitor
Will FDA advisers shoot down Amgen's cancer vaccine?
Fierce Biotech
Thu, 02/12/15 - 02:15 pm
FDA
Amgen
vaccines
T-Vec
melanoma
Pfizer to Skip Melanoma in Bid to Join Cancer Race
Bloomberg
Thu, 01/15/15 - 08:48 am
Pfizer
melanoma
Merck KGaA
R&D
Merck CEO Frazier credits Keytruda success to slim-down strategy
Fierce Pharma
Tue, 01/13/15 - 10:47 am
Merck
Pharma CEOs
Kenneth Frazier
Keytruda
Yervoy
melanoma

Pages